• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharmaceuticals

SNW2:GR

37.970 EUR 0.249 0.66%

As of 03:05:51 ET on 07/30/2014.

Snapshot for Sanofi (SNW2)

Open: 38.255 Day's Range: 37.945 - 38.255 Volume: 0
Previous Close: 37.721 52wk Range: 34.433 - 40.383 1-Yr Rtn: +0.22%

Stock Chart for SNW2

No chart data available.
  • SNW2:GR 37.970
  • 1D
  • 1M
  • 1Y
37.721
Interactive SNW2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNW2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 14.5926
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.6020
Est. PEG Ratio 1.8150
Market Cap (M EUR) 100,302.28
Shares Outstanding (M) 2,641.62
30 Day Average Volume 245
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.57%
Cash Dividend (USD) 1.5983
Dividend Ex-Date 05/07/2014
5 Year Dividend Growth 3.30%
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNW2

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SNW2

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergChairmanChristopher A Viehbacher "Chris"Chief Executive Officer
Anne C BealChief Patient OfficerElias A ZerhouniPres:Global Research & Dev
More Company Profile & Key Executives for SNW2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil